PURPOSE: To investigate the contribution of CDKN2A A148T common variant to early-onset breast cancer in Poland, and to establish the characteristic features of these cancers. EXPERIMENTAL DESIGN: We studied 3,069 women diagnosed with breast cancer under the age of 51 and 3,493 population controls. CDKN2A variant were detected using RFLP-PCR and confirmed by genomic sequencing. Clinical and pathological features of CDKN2A-positive cases and CDKN2A-negative cases were compared. RESULTS: A148T variant was identified in 157 of 3,069 women with breast cancer (5.1%). Overall, the odds ratio for early-onset breast cancer, given a CDKN2A variant was 1.4 (95% CI 1.075-1.725; P = 0.012). Breast tumors in women with the CDKN2A variant were more commonly intraductal cancers (DCIS) with micro-invasion (14.8% vs. 8.5%; P = 0.035). Carriers and non-carriers were similar with respect to tumor size, laterality, multicentricity, nodal status, family history and estrogen-receptor status. CONCLUSION: The CDKN2A A148T variant seems to contribute to early-onset breast cancer in Poland. Breast tumors which arise in carriers of A148T variant appear to be similar to those of breast cancers in the population at large.
PURPOSE: To investigate the contribution of CDKN2AA148T common variant to early-onset breast cancer in Poland, and to establish the characteristic features of these cancers. EXPERIMENTAL DESIGN: We studied 3,069 women diagnosed with breast cancer under the age of 51 and 3,493 population controls. CDKN2A variant were detected using RFLP-PCR and confirmed by genomic sequencing. Clinical and pathological features of CDKN2A-positive cases and CDKN2A-negative cases were compared. RESULTS:A148T variant was identified in 157 of 3,069 women with breast cancer (5.1%). Overall, the odds ratio for early-onset breast cancer, given a CDKN2A variant was 1.4 (95% CI 1.075-1.725; P = 0.012). Breast tumors in women with the CDKN2A variant were more commonly intraductal cancers (DCIS) with micro-invasion (14.8% vs. 8.5%; P = 0.035). Carriers and non-carriers were similar with respect to tumor size, laterality, multicentricity, nodal status, family history and estrogen-receptor status. CONCLUSION: The CDKN2AA148T variant seems to contribute to early-onset breast cancer in Poland. Breast tumors which arise in carriers of A148T variant appear to be similar to those of breast cancers in the population at large.
Authors: Elżbieta Złowocka-Perłowska; Thierry van de Wetering; Aleksandra Tołoczko-Grabarek; Rodney J Scott; Jan Lubiński Journal: Oncotarget Date: 2022-04-22
Authors: Michael S Cunnington; Mauro Santibanez Koref; Bongani M Mayosi; John Burn; Bernard Keavney Journal: PLoS Genet Date: 2010-04-08 Impact factor: 5.917
Authors: Patrick Lebok; Magdalena Roming; Martina Kluth; Christina Koop; Cansu Özden; Berivan Taskin; Khakan Hussein; Annette Lebeau; Isabell Witzel; Linn Wölber; Stefan Geist; Peter Paluchowski; Christian Wilke; Uwe Heilenkötter; Volkmar Müller; Barbara Schmalfeldt; Ronald Simon; Guido Sauter; Luigi Terracciano; Rainer Horst Krech; Albert von der Assen; Eike Burandt Journal: Oncotarget Date: 2016-12-06
Authors: Kristy E Driver; Honglin Song; Fabienne Lesueur; Shahana Ahmed; Nuno L Barbosa-Morais; Jonathan P Tyrer; Bruce A J Ponder; Douglas F Easton; Paul D P Pharoah; Alison M Dunning Journal: Carcinogenesis Date: 2008-01-03 Impact factor: 4.944